Debora Barbosa Vendramini-Costa

8PUBLICATIONS
78CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersCancer cell biologyRadiation therapyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 01, 2026
Keloid transcriptomics reveal heterogeneity in fibroblast subtype enrichment, gene expression, and immune cell responses.

|Dec 05, 2024
Human Pancreatic Cancer Single-Cell Atlas Reveals Association of CXCL10+ Fibroblasts and Basal Subtype Tumor Cells.

Ian M Loveless, Samantha B Kemp, Kailee M Hartway

|Sep 16, 2024
Pancreatic Cancer-Associated Fibroblasts: Where Do We Go from Here?

Eileen S Carpenter, Debora Barbosa Vendramini-Costa, Marie C Hasselluhn

|May 27, 2024
Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancer.

Débora B Vendramini-Costa, Ralph Francescone, Janusz Franco-Barraza

|Jan 31, 2024
Pulsed low-dose-rate radiation (PLDR) reduces the tumor-promoting responses induced by conventional chemoradiation in pancreatic cancer-associated fibroblasts.

Janusz Franco-Barraza, Tiffany Luong, Jessica K Wong

|Sep 25, 2023
Trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer growth and immune suppression via phospholipid scramblase anoctamin 6 (ANO6).

Charline Ogier, Akino Mercy Charles Solomon, Zhen Lu

Pageof 2

Frequent Collaborators

5 joint publications

Edna Cukierman

4 joint publications

Ralph Francescone

3 joint publications

Janusz Franco-Barraza

2 joint publications

Ling Huang